NUCLEAR MEDICINE COMMUNICATIONS, cilt.33, sa.5, ss.509-515, 2012 (SCI-Expanded)
Objective The aim of this study was to evaluate the diagnostic value of 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (F-18-FDG) PET/CT in comparison with MRI for the detection of recurrent ovarian cancer.